BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 33097683)

  • 1. Delayed Presentation of Acute Generalized Exanthematous Pustulosis Following Treatment with Cefepime in a Patient with COVID-19 without the Use of Hydroxychloroquine.
    Haraszti S; Sendil S; Jensen N
    Am J Case Rep; 2020 Oct; 21():e926901. PubMed ID: 33097683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
    Coleman I; Ruiz G; Brahmbhatt S; Ackerman L
    J Med Case Rep; 2020 Nov; 14(1):210. PubMed ID: 33138853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia.
    Pezzarossa E; Ungari M; Caresana G; Sagradi F; Cimardi L; Pan A; Testa S; Aguggini S; Varotti E; Tanzi G; Manotti L; Ferrero G; Gusolfino MD; Trombatore M;
    Am J Dermatopathol; 2021 May; 43(5):342-348. PubMed ID: 33405402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged pustular eruption from hydroxychloroquine: an unusual case of acute generalized exanthematous pustulosis.
    Pearson KC; Morrell DS; Runge SR; Jolly P
    Cutis; 2016 Mar; 97(3):212-6. PubMed ID: 27023083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: first case report in Canada and review of the literature.
    Bailey K; McKee D; Wismer J; Shear N
    J Cutan Med Surg; 2013; 17(6):414-8. PubMed ID: 24138979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore.
    Lee HY; Chou D; Pang SM; Thirumoorthy T
    Int J Dermatol; 2010 May; 49(5):507-12. PubMed ID: 20534083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Amoxicillin-Induced Acute Generalized Exanthematous Pustulosis Presenting as Septic Shock.
    McDonald KA; Pierscianowski TA
    J Cutan Med Surg; 2017; 21(4):351-355. PubMed ID: 28358593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 presenting as acute generalized exanthematous pustulosis associated with multiorgan dysfunction in a 44-year-old female patient.
    Ordoñez NA; Sepulveda VG; Vargas LP; Moreno JM
    Rev Inst Med Trop Sao Paulo; 2021; 63():e42. PubMed ID: 34037158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The First Pediatric Case of Acute Generalized Exanthematous Pustulosis Caused by Hydroxychloroquine.
    Liccioli G; Marrani E; Giani T; Simonini G; Barni S; Mori F
    Pharmacology; 2019; 104(1-2):57-59. PubMed ID: 31067554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute generalized exanthematous pustulosis secondary to levetiracetam and valproic acid use.
    Levy ZD; Slowey M; Schulder M
    Am J Emerg Med; 2017 Jul; 35(7):1036.e1-1036.e2. PubMed ID: 28189379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole-induced acute generalized exanthematous pustulosis.
    Saliba E; Chrabieh R; Tannous Z
    Am J Emerg Med; 2021 Jan; 39():254.e5-254.e7. PubMed ID: 32641264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.
    Litaiem N; Hajlaoui K; Karray M; Slouma M; Zeglaoui F
    Dermatol Ther; 2020 Jul; 33(4):e13565. PubMed ID: 32401410
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: a case with atypical clinical presentation.
    Duman H; Topal IO; Kocaturk E; Cure K; Mansuroglu I
    An Bras Dermatol; 2017; 92(3):404-406. PubMed ID: 29186260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation and management of atypical and recalcitrant acute generalized exanthematous pustulosis.
    Hadavand MA; Kaffenberger B; Cartron AM; Trinidad JCL
    J Am Acad Dermatol; 2022 Sep; 87(3):632-639. PubMed ID: 32926975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute generalized exanthematous pustulosis with a focus on hydroxychloroquine: A 10-year experience in a skin hospital.
    Nili A; Zarei E; Ghamari A; Farid AS; Tavakolpour S; Daneshpazhooh M; Mahmoudi H
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107093. PubMed ID: 33091817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pustular Psoriasis and Acute Generalized Exanthematous Pustulosis.
    Sussman M; Napodano A; Huang S; Are A; Hsu S; Motaparthi K
    Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute generalized exanthematous pustulosis associated with clindamycin in a patient with Hailey-Hailey disease.
    Casillas AC; Barragan VA; Alhalaseh Y; Modi MB; Lake E; Speiser JJ
    J Cutan Pathol; 2023 Oct; 50(10):864-868. PubMed ID: 37430411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute generalized exanthematous pustulosis induced by piroxicam: a case report.
    Cherif Y; Jallouli M; Mseddi M; Turki H; Bahloul Z
    Indian J Pharmacol; 2014; 46(2):232-3. PubMed ID: 24741202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19.
    Delaleu J; Deniau B; Battistella M; de Masson A; Bensaid B; Jachiet M; Lazaridou I; Bagot M; Bouaziz JD;
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2777-2779.e1. PubMed ID: 32525093
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute generalized exanthematous pustulosis caused by hydroxychloroquine in a patient with rheumatoid arthritis and CARD14 mutation: Case report.
    Luo F; Yuan XM; Xiong H; Chen CM; Ma WK; Yao XM
    Medicine (Baltimore); 2023 Nov; 102(47):e36168. PubMed ID: 38013380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.